Cardionyx Heart Science Israeli Company

Cardionyx is developing an active implant to stimulate baroreceptors for Heart Failure (HF) patients, through a minimally invasive approach. Cardionyx stands at the forefront of medical innovation, poised to address the critical clinical needs of Heart Failure (HF) patients with reduced ejection fraction (HFrEF) through its groundbreaking approach.